|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yang JD and Roberts LR: Hepatocellular
carcinoma: A global view. Nat Rev Gastroenterol Hepatol. 7:448–458.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Forner A, Llovet JM and Bruix J:
Hepatocellular carcinoma. Lancet. 379:1245–1255. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sherman M: Hepatocellular carcinoma:
Epidemiology, surveillance, and diagnosis. Semin Liver Dis.
30:3–16. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Beasley RP, Hwang LY, Lin CC and Chien CS:
Hepatocellular carcinoma and hepatitis B virus. A prospective study
of 22 707 men in Taiwan. Lancet. 2:1129–1133. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Grimm D, Bauer J, Wise P, Krüger M,
Simonsen U, Wehland M, Infanger M and Corydon TJ: The role of SOX
family members in solid tumours and metastasis. Semin Cancer Biol.
Mar 23–2019.(Epub ahead of print). doi:
10.1016/j.semcancer.2019.03.004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
van Houte LP, Chuprina VP, van der
Wetering M, Boelens R, Kaptein R and Clevers H: Solution structure
of the sequence-specific HMG box of the lymphocyte transcriptional
activator Sox-4. J Biol Chem. 270:30516–30524. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rhodes DR, Yu J, Shanker K, Deshpande N,
Varambally R, Ghosh D, Barrette T, Pandey A and Chinnaiyan AM:
Large-scale meta-analysis of cancer microarray data identifies
common transcriptional profiles of neoplastic transformation and
progression. Proc Natl Acad Sci USA. 101:9309–9314. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hur W, Rhim H, Jung CK, Kim JD, Bae SH,
Jang JW, Yang JM, Oh ST, Kim DG, Wang HJ, et al: SOX4
overexpression regulates the p53-mediated apoptosis in
hepatocellular carcinoma: Clinical implication and functional
analysis in vitro. Carcinogenesis. 31:1298–1307. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Treiber T, Treiber N and Meister G:
Regulation of microRNA biogenesis and function. Thromb Haemost.
107:605–610. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jafri MA, Al-Qahtani MH and Shay JW: Role
of miRNAs in human cancer metastasis: Implications for therapeutic
intervention. Semin Cancer Biol. 44:117–131. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kogure A, Kosaka N and Ochiya T:
Cross-talk between cancer cells and their neighbors via miRNA in
extracellular vesicles: An emerging player in cancer metastasis. J
Biomed Sci. 26:72019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhao DW, Hou YS, Sun FB, Han B and Li SJ:
Effects of miR-132 on proliferation and apoptosis of pancreatic
cancer cells via Hedgehog signaling pathway. Eur Rev Med Pharmacol
Sci. 23:1978–1985. 2019.PubMed/NCBI
|
|
15
|
Chen Y, Zhu H, Wang Y, Song Y, Zhang P,
Wang Z, Gao J, Li Z and Du Y: MicroRNA-132 plays an independent
prognostic role in pancreatic ductal adenocarcinoma and acts as a
tumor suppressor. Technol Cancer Res Treat.
18:15330338188243142019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu Y and Zhang M: MiR-132 regulates
adriamycin resistance in colorectal cancer cells through targeting
extracellular signal-regulated kinase 1. Cancer Biother Radiopharm.
4:398–404. 2019. View Article : Google Scholar
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Song K, Han C, Zhang J, Lu D, Dash S,
Feitelson M, Lim K and Wu T: Epigenetic regulation of MicroRNA-122
by peroxisome proliferator activated receptor-gamma and hepatitis b
virus X protein in hepatocellular carcinoma cells. Hepatology.
58:1681–1692. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lei CJ, Li L, Gao X, Zhang J, Pan QY, Long
HC, Chen CZ, Ren DF and Zheng G: Hsa-miR-132 inhibits proliferation
of hepatic carcinoma cells by targeting YAP. Cell Biochem Funct.
33:326–333. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu K, Li X, Cao Y, Ge Y, Wang J and Shi
B: MiR-132 inhibits cell proliferation, invasion and migration of
hepatocellular carcinoma by targeting PIK3R3. Int J Oncol.
47:1585–1593. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wei X, Tan C, Tang C, Ren G, Xiang T, Qiu
Z, Liu R and Wu Z: Epigenetic repression of miR-132 expression by
the hepatitis B virus × protein in hepatitis B virus-related
hepatocellular carcinoma. Cell Signal. 25:1037–1043. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kara M, Yumrutas O, Ozcan O, Celik OI,
Bozgeyik E, Bozgeyik I and Tasdemir S: Differential expressions of
cancer-associated genes and their regulatory miRNAs in colorectal
carcinoma. Gene. 567:81–86. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang H, Li XT, Wu C, Wu ZW, Li YY, Yang
TQ, Chen GL, Xie XS, Huang YL, Du ZW and Zhou YX: MiR-132 can
inhibit glioma cells invasion and migration by target MMP16 in
vitro. Onco Targets Ther. 8:3211–3218. 2015.PubMed/NCBI
|
|
24
|
Zhang H, Liu A, Feng X, Tian L, Bo W, Wang
H and Hu Y: MiR-132 promotes the proliferation, invasion and
migration of human pancreatic carcinoma by inhibition of the tumor
suppressor gene PTEN. Prog Biophys Mol Biol. 148:65–72. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhou K, Zhang C, Yao H, Zhang X, Zhou Y,
Che Y and Huang Y: Knockdown of long non-coding RNA NEAT1 inhibits
glioma cell migration and invasion via modulation of SOX2 targeted
by miR-132. Mol Cancer. 17:1052018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wu WK, Lee CW, Cho CH, Fan D, Wu K, Yu J
and Sung JJ: MicroRNA dysregulation in gastric cancer: A new player
enters the game. Oncogene. 29:5761–5771. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu Y, Li Y, Liu J, Wu Y and Zhu Q:
MicroRNA-132 inhibits cell growth and metastasis in osteosarcoma
cell lines possibly by targeting Sox4. Int J Oncol. 47:1672–1684.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li Y, Zu L, Wang Y, Wang M, Chen P and
Zhou Q: MiR-132 inhibits lung cancer cell migration and invasion by
targeting SOX4. J Thorac Dis. 7:1563–1569. 2015.PubMed/NCBI
|
|
29
|
Zheng YB, Luo HP, Shi Q, Hao ZN, Ding Y,
Wang QS, Li SB, Xiao GC and Tong SL: miR-132 inhibits colorectal
cancer invasion and metastasis via directly targeting ZEB2. World J
Gastroenterol. 20:6515–6522. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li Y, Zhang J, He J, Zhou W, Xiang G and
Xu R: MicroRNA-132 cause apoptosis of glioma cells through blockade
of the SREBP-1c metabolic pathway related to SIRT1. Biomed
Pharmacother. 78:177–184. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang L, Zhang J, Yang X, Chang YW, Qi M,
Zhou Z, Zhang J and Han B: SOX4 is associated with poor prognosis
in prostate cancer and promotes epithelial-mesenchymal transition
in vitro. Prostate Cancer Prostatic Dis. 16:301–307. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang H, Alberich-Jorda M, Amabile G, Yang
H, Staber PB, Di Ruscio A, Welner RS, Ebralidze A, Zhang J,
Levantini E, et al: Sox4 is a key oncogenic target in C/EBPα mutant
acute myeloid leukemia. Cancer Cell. 24:575–588. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhou Y, Wang X, Huang Y, Chen Y, Zhao G,
Yao Q, Jin C, Huang Y, Liu X and Li G: Down-regulated SOX4
expression suppresses cell proliferation, metastasis and induces
apoptosis in Xuanwei female lung cancer patients. J Cell Biochem.
116:1007–1018. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang J, Liang Q, Lei Y, Yao M, Li L, Gao
X, Feng J, Zhang Y, Gao H, Liu DX, et al: SOX4 induces
epithelial-mesenchymal transition and contributes to breast cancer
progression. Cancer Res. 72:4597–4608. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Castillo SD, Matheu A, Mariani N,
Carretero J, Lopez-Rios F, Lovell-Badge R and Sanchez-Cespedes M:
Novel transcriptional targets of the SRY-HMG box transcription
factor SOX4 link its expression to the development of small cell
lung cancer. Cancer Res. 72:176–186. 2012. View Article : Google Scholar : PubMed/NCBI
|
